Latest news and updates about the Medicare and pharmacy industries.

July 12: Novartis Epinephrine Shots Will Soon Be Available in U.S. Pharmacies

Posted on in Industry Updates by Amplicare Team

Plus, the latest pharmacy and healthcare news to know this week

The Story

On Tuesday, Novartis announced that it would be making its Symjepi epinephrine shots available to local pharmacies in the U.S.. The generic pre-filled epinephrine shots, which have been used in hospitals since January, will soon be sold at retail pharmacies in both adult (0.3 mg) and pediatric (0.15 mg) doses. The increased availability of Symjepi is extremely important as epinephrine auto-injector shortages persist.

Why it Matters

Pharmacies and patients have seen a shortage of EpiPens since May 2018, according to Bloomberg. Produced by Mylan, EpiPens are currently the leading treatment for severe allergic reactions. However, manufacturing delays have resulted in difficulty accessing this medication, a trend which is expected to continue in the coming months. 

Novartis’ alternative, Symjepi, is a small, single-dose, pre-filled syringe and device combination used for the emergency treatment of allergic reactions. This includes treatment of anaphylaxis which is a severe reaction to stinging and biting insects, foods, drugs, diagnostic testing substances and other allergens. It’s availability now is particularly noteworthy as demand of epinephrine-auto injectors are known to rise in the summer when parents renew prescriptions in preparation for summer camp and the new school year. Every year, as many as 200,000 people nationwide need emergency medical care for allergic reactions to food, so making these epinephrine shots more readily available is a welcome move to pharmacists and patients alike.  

More healthcare news to watch:

  1. On Monday, a federal judge blocked a new Trump Administration rule requiring drugmakers to disclose list prices in TV ads just hours before the new rule was set to take effect. NPR.
  2. House Speaker Nancy Pelosi’s latest proposal would give the U.S. Department of Health and Human Services the authority to negotiate lower drug prices for Medicare and private health plans. CNBC.
  3. Albertsons pharmacy is taking full advantage of a new Idaho law allowing pharmacy technicians to prescribe naloxone. Drug Store News.
  4. A new study suggests that mandates requiring clinicians to co-prescribe naloxone with opioids to high-risk patients increase naloxone dispensing. APhA.
  5. MLK Health Center’s free pharmacy in Louisiana helps nearly 2,000 patients who cannot afford their medications. KSLA.

Other Articles

Posted on by Amplicare Team

Medicare Advantage: What’s Changed for 2020

Earlier this year, CMS released updates to Medicare Advantage and Part D programs for the upcoming plan year. As...
Continue Reading

Posted on by Amplicare Team

June 28: A New Bill Aims to Increase Access to Vaccinations

A bipartisan bill could help provide shingles and Tdap vaccinations to Medicare beneficiaries at no extra cost, and more...
Continue Reading

Posted on by Amplicare Team

What to Consider When Talking to Patients About Naloxone

Despite the known benefits of naloxone, approaching the conversation about its necessity with patients is not always easy for...
Continue Reading

Posted on by Amplicare Team

June 21: Pharma Companies Sue to Oppose Listing Drug Prices in TV Ads

Drug makers are suing the government to block a new rule requiring drug prices in TV ads, and more...
Continue Reading